CannLabs, Inc.
CANL · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -0.35 | 0.07 |
| FCF Yield | 5.19% | 3.72% | 0.54% | 0.29% |
| EV / EBITDA | 15.94 | 74.09 | 98.17 | 78.55 |
| Quality | ||||
| ROIC | 11.58% | 3.48% | 3.73% | 10.07% |
| Gross Margin | 52.12% | 36.52% | 43.42% | 55.79% |
| Cash Conversion Ratio | 0.93 | 2.98 | 0.56 | 0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | 36.60% | 42.96% | 64.70% | 112.00% |
| Free Cash Flow Growth | 10.23% | 391.42% | -6.46% | 407.13% |
| Safety | ||||
| Net Debt / EBITDA | -1.77 | -3.84 | -2.87 | -0.90 |
| Interest Coverage | 354.77 | 131.21 | 150.38 | 580.90 |
| Efficiency | ||||
| Inventory Turnover | 0.67 | 0.81 | 0.67 | 0.52 |
| Cash Conversion Cycle | 176.16 | 163.18 | 195.73 | 243.33 |